Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Francesca Conti
Observed names:
F Conti,
F. Conti
Institution:
Instituto Nazionale Tumori Regina Elena
Observed institutions:
Ospedale San Filippo Neri,
Azienda Ospedaliera Sant'Andrea,
St. Eugenio Hospital,
Instituto Nazionale Tumori Regina Elena,
Sapienza University of Rome
OpenAlex ID:
A5109317818
Triple positive breast cancer: A distinct subtype?
2014
·
Patrizia Vici
, Laura Pizzuti
, et al.
·
Cancer Treatment Reviews
·
138
PDF
Impact of Five Prophylactic Filgrastim Schedules on Hematologic Toxicity in Early Breast Cancer Patients Treated With Epirubicin and Cyclophosphamide
2005
·
Paola Papaldo
, Massimo Lopez
, et al.
·
Journal of Clinical Oncology
·
99
PDF
Addition of Either Lonidamine or Granulocyte Colony-Stimulating Factor Does Not Improve Survival in Early Breast Cancer Patients Treated With High-Dose Epirubicin and Cyclophosphamide
2003
·
Paola Papaldo
, Massimo Lopez
, et al.
·
Journal of Clinical Oncology
·
84
First-Line Treatment With Epirubicin and Vinorelbine in Metastatic Breast Cancer
2002
·
Patrizia Vici
, Giuseppe Colucci
, et al.
·
Journal of Clinical Oncology
·
38
Docetaxel in Patients with Anthracycline-Resistant Advanced Breast Cancer
2000
·
Patrizia Vici
, Franca Belli
, et al.
·
Oncology
·
19
First-Line Chemotherapy with Vinorelbine and Paclitaxel as Simultaneous Infusion in Advanced Breast Cancer
2000
·
Patrizia Vici
, Antonella Amodio
, et al.
·
Oncology
·
15
Intrapatient comparison of single-agent epirubicin with or without lonidamine in metastatic breast cancer
1995
·
M. Lopez
, P. Vici
, et al.
·
European Journal of Cancer
·
13
High activity of salvage treatment with biweekly paclitaxel-gemcitabine combination in heavily pretreated breast cancer patients.
2006
·
P Vici
, E Capomolla
, et al.
·
PubMed
·
11
Non-Pegylated Liposomal Doxorubicin-Cyclophosphamide in Sequential Regimens with Taxanes as Neoadjuvant Chemotherapy in Breast Cancer Patients
2014
·
Patrizia Vici
, Laura Pizzuti
, et al.
·
Journal of Cancer
·
9
PDF
Phase I–II trial of prolonged gemcitabine infusion plus paclitaxel as a biweekly schedule for advanced breast cancer patients pretreated with anthracyclines
2010
·
Patrizia Vici
, Alessandra Fabi
, et al.
·
Cancer Chemotherapy and Pharmacology
·
9
Paclitaxel Activity in Anthracycline Refractory Breast Cancer Patients
1997
·
Patrizia Vici
, Luigi Di Lauro
, et al.
·
Tumori Journal
·
9
[High-dose CEF (cyclophosphamide, epirubicin, fluorouracil) as primary chemotherapy in locally advanced breast cancer: long-term results].
2007
·
F Conti
, S Carpano
, et al.
·
PubMed
·
5
[Target selectivity of anticancer drugs].
2008
·
S I S Fattoruso
, L Di Lauro
, et al.
·
PubMed
·
3
[New combination chemotherapy regimens in the primary treatment of operable breast cancer].
2007
·
F Conti
, D Sergi
, et al.
·
PubMed
·
3
[Adjuvant chemotherapy in hormone-receptor positive HER2-negative early breast cancer].
2009
·
M Lopez
, L Di Lauro
, et al.
·
PubMed
·
2
[Simultaneous infusion of vinorelbin and taxol as first-line chemotherapy in metastasized breast cancer].
1998
·
P Vici
, F Conti
, et al.
·
PubMed
·
2
[Neoadjuvant endocrine therapy for locally advanced breast cancer].
2007
·
G Viola
, D Sergi
, et al.
·
PubMed
·
1
High-dose CEF (cyclophosphamide, epirubicin, fluorouracil) as primary chemotherapy in locally advanced breast cancer: Long term survival data
2008
·
F. Conti
, P. Perri
, et al.
·
European Journal of Cancer Supplements
Show more works
View as search
Works count:
18
Citation count:
460
H-index:
9
I10-index:
8
Year
Topic
Type